Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × tremelimumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 23 Carcinoma, Non-Small-Cell Lung 11 Lung Neoplasms 6 Liver Neoplasms 6 Small Cell Lung Carcinoma 4 Diabetes Mellitus, Insulin-Dependent, 12 4 Cholangiocarcinoma 4 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Biliary Tract Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Mesothelioma 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vascular Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Unresectable Hepatocellular Carcinoma 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1

Interventions

Gemcitabine 17 Mitomycin 9 Docetaxel 6 erdafitinib 5 dodecyl maltoside 4 Cystoscopy 4 BCG Vaccine 4 durvalumab 2 Radiotherapy 2 ALT-803 2 5-aminolevulinic acid hexyl ester 2 viscum album peptide 1 toripalimab 1 pirarubicin 1 pemigatinib 1 monalizumab 1 hydroxycamptothecinum 1 enfortumab vedotin 1 bicalutamide 1 Urine Specimen Collection 1 Transurethral Resection of Bladder 1 Surveys and Questionnaires 1 Patient Discharge 1 Paclitaxel 1 Nonsteroidal Anti-Androgens 1 Mitozytrex 1 Maintenance 1 Magnetic Resonance Spectroscopy 1 Injections 1 Imiquimod 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡